Kenneth M. Ferguson

Board Director

Director

US·SEC (Form 4)

Cyclacel Pharmaceuticals, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 03 Jul 2023 for Cyclacel Pharmaceuticals, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Kenneth M. Ferguson: trading record in brief

Kenneth M. Ferguson, listed as board member, appears in our data through filings on Bio Green Med Solution, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 14 June 2022 and the latest from 30 June 2023.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 3 July 2023: a share grant, in Bio Green Med Solution, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.